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Electrophysiological studyAbstract Behc¸et’s disease (BD) is a chronic inﬂammatory disease which is best described as a
multisystem vasculitis. Central nervous system involvement is common in BD, but peripheral nerve
involvement is uncommon.
Aim of the work: To determine peripheral nerve involvement; both clinically and electrophysio-
logically in Behc¸et patients and to study its relation to disease duration and activity scores.
Patients and methods: This study was carried out on 18 patients suffering from BD. Disease
activity was assessed by Behc¸et Disease Current Activity Form (BDCAF). Peripheral neuropathy
was assessed by the reduced version of the Total Neuropathy Score. Electrophysiological studies
including nerve conduction studies and F waves of peripheral nerves were performed on all patients.
Results: There was a signiﬁcant difference in the percentage of sensory and motor nerve affec-
tion (p< 0.05) in BD patients. Sural nerve latencies and conduction velocities were abnormal in
50% of patients on the right and in 44.4% of patients on the left side. Sural nerve latencies were
signiﬁcantly correlated with disease duration (p< 0.05 for right side and p< 0.01 for left side).
Correlations between F wave frequencies and disease duration were signiﬁcant for right and left
peroneal nerves (p< 0.01 and p< 0.05 respectively) and highly signiﬁcant for right and left median
nerves (p< 0.001).
Conclusion: Peripheral nerve involvement is present in BD. The longer the disease duration; the
more is the affection of the peripheral nerves. Full neurological assessment and electrophysiological
studies are necessary in the follow up of Behc¸et patients.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases.1. Introduction
Behc¸et’s disease (BD) is a chronic inﬂammatory disease which
is best described as a multi-system vasculitis, and is associated
with protean manifestations including mucocutaneous lesions,
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arthritis [1]. The ﬁrst description of Behc¸et’s disease was prob-
ably by Hippocrates in the ﬁfth century BC [2] and the ﬁrst
modern account was presented in 1937 by the Turkish derma-
tologist Hulusi Behc¸et, who reported a patient with recurrent
oral and genital aphthae and uveitis [3].
The classiﬁcation of this condition depends on the pres-
ence of clinical features as deﬁned by the International
Study Group (ISG) on Behc¸et’s Disease [4]. Aphthous oral
ulcers are usually the ﬁrst and most persistent clinical fea-
ture of BD. Lesions occur in crops and are discrete, painful,
round or oval red-rimmed lesions that affect mainly the non
keratinized mucosa of the cheeks, the border of the tongue,
the soft palate, and the pharynx. Genital ulcers occur as
single or multiple lesions of the vulva, vagina, scrotum or
penile shaft and are usually painful and may result in
scarring [5].
Ophthalmologic manifestations of Behc¸et’s disease include
anterior/posterior uveitis, conjunctivitis, corneal ulceration,
papillitis and arteritis [6]. Uveitis is the most common type
of eye involvement in Behc¸et’s disease. It is usually chronic,
bilateral and episodic often involving the entire uveal tract.
Hypopyon is associated with a poor prognosis owing to its
association with retinal vasculitis [7].
Neuro-BD is more frequent in young males and it never
represents a presenting feature of the disease. The most fre-
quent time of onset of neurological involvement seems to
be within the ﬁrst 10 years of disease [8]. In a study on 53
Egyptian patients with BD, 39.62% had neuro-BD and the
disease activity score was signiﬁcantly higher in those with
neuro-Behc¸ets compared to those without [9]. In another
study, neurological manifestations were present in 20.41%
BD Egyptian patients [10]. In neuro-BD (NBD), the CNS
can be involved in two ways: ﬁrst, and most commonly,
through the development of an immune-mediated meningoen-
cephalitis, which predominantly involves the brainstem, but
can also involve the basal ganglia, thalamus, cortex and white
matter, spinal cord, or cranial nerves; and second, as a con-
sequence of thrombosis within the dural venous sinuses [11].
Brainstem involvement bears a poorer prognosis because it is
linked with a progressive evolution [12]. Neuro-Behc¸et’s dis-
ease (NBD) presents cognitive and behavioral symptoms
[13]. The headache in NBD may be subacute, moderate to
severe headache with unilateral localization and throbbing
quality accompanied by nausea, vomiting, and aggravation
upon awakening [14]. Ruptured aneurysms, peripheral neu-
ropathy, optic neuritis, and vestibular involvement can occur
[15]. Behc¸et patients may have subclinical peripheral nerve
involvement. The frequency of neuropathy was higher in
the patients with BD when compared with the control sub-
jects [16].
Although peripheral neuropathy is uncommon [17], con-
ventional electrophysiologic nerve conduction studies includ-
ing F responses are recommended in a routine examination
to diagnose early neuropathy in Behc¸et patients.
The aim of this study was to evaluate the peripheral
nervous system of BD patients electrophysiologically and to
ﬁnd out if electrophysiological abnormalities are correlated
with disease duration and activity scores or not.2. Patients and methods
2.1. Selection of patients
Eighteen patients diagnosed as BD were enrolled into this
study. They were selected from the inpatient departments
and outpatient clinics of Rheumatology and Rehabilitation
and of Dermatology, Venereology and Andrology Depart-
ments, Faculty of Medicine, Zagazig University Hospitals.
All patients fulﬁlled the criteria of the International Study
Group (ISG) for BD [4]. Patients with diabetes mellitus, hered-
itary neuropathies or those with symptoms of motor or sen-
sory impairment prior to the onset of BD were excluded
from the study.
The study was approved by the Local Ethics Committee of
the university. An informed consent was obtained from each
patient.
2.2. Clinical evaluation of patients
Active and inactive BD was determined by using BD current
Activity score form (BDCAF) [18]. It depends on the presence
of symptoms over the last 4 weeks prior to assessment.
We used the reduced version of the Total Neuropathy Score
(TNS) for neurological assessment of the patients [19]. It com-
prises ﬁve categories, each graded from 0 to 4, for a total score
range of 0–20 points. Categories included the extent and sever-
ity of sensory and motor symptom reports, assessment of deep
tendon reﬂexes, muscle strength testing, vibration sensibility
(128-Hz tuning fork), and pin prick sensibility.
2.3. Electrophysiological studies
Electrophysiological studies of the upper and lower limbs were
performed at room temperature, using Viking Quest Nicolet
electromyography equipment. Motor and sensory conduction
studies of the median and ulnar nerves and median nerve F-
wave latencies and frequencies were assessed bilaterally. Motor
conduction studies of tibial and peroneal nerves, sensory con-
duction studies of sural nerve and peroneal nerve F-wave were
also assessed bilaterally. Superﬁcial disk electrodes were used
for motor and sensory conduction studies. Electrophysiologi-
cal studies and normal reference values were evaluated accord-
ing to the description of Preston and Shapiro [20].
For motor conduction studies, the recording electrodes
were placed over the abductor pollicis brevis muscle for the
median nerve, the adductor digiti minimi muscle for the ulnar
nerve, the extensor digitorum brevis muscle for the peroneal
nerve and the abductor hallucis brevis muscle for the tibial
nerve. The active recording electrode was placed on the belly
of the examined muscle and the reference electrode was placed
on the tendon insertion.
Sensory conduction studies were performed using the anti-
dromic method. Digit2-wrist segment was used for median sen-
sory nerve conduction studies. Digit5-wrist segment was used
for ulnar sensory nerve conduction studies. Sensory conduc-
tion studies of the sural nerve were performed by placing the
recording electrode posterior to the lateral malleolus and the
Table 1 Demographic and clinical characteristics in Behc¸et’s
disease patients.
Characteristic Range Mean ± SD
Age (years) 19–43 30.67 ± 9.91
Disease duration (years) 2–17 6.83 ± 4.27
BDCAF score 0–13 6.61 ± 3.45
TNS 0–2 1.50 ± 2.38
Clinical items of BDCAF No. (%)
Headache 6 (33.3)
Oral ulceration 9 (50)
Genital ulceration 4 (22.2)
Erythema 2 (11.1)
Skin pustules 4 (22.2)
Arthralgia 10 (55.6)
Arthritis 2 (11.1)
Nausea/vomiting/abdominal pain 8 (44.4)
Diarrhea + altered/frank blood per rectum 3 (16.7)
Eye involvement 7 (38.9)
CNS involvement 4 (22.2)
Major vessel involvement 2 (11.1)
TNS: Total Neuropathy Score, BDCAF: Behc¸et Disease Current
Activity Form.
Table 2 Nerve conduction study ﬁndings in Behc¸et’s disease
patients.
Range Mean ± SD
Ulnar n. sensory latency (right) 2.5–3.6 2.29 ± 0.34
(left) 2.6–3.7 2.97 ± 0.33
Sural n. latency (right) 3.8–5.2 4.48 ± 0.56
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nerve at the posterolateral aspect of the leg 14 cm proximal
to the active electrode.
F-wave study was performed for the median and peroneal
nerves by recording from the samemuscles used for motor stud-
ies. An active stimulating electrode was placed proximally and
at least 10 successive supra-maximal stimulations were given.
Minimum F-wave latencies and frequencies were recorded.
Motor nerve conduction velocities were considered abnor-
mal if below 49 m/s for the upper limb or below 44 m/s for
the lower limb. Distal motor latencies were considered pro-
longed if higher than 4.4 ms for the median nerve, 3.3 ms for
the ulnar nerve, 6.5 ms for the peroneal nerve and 5.8 ms for
the tibial nerve.
Sensory nerve conduction velocity of the median and ulnar
nerves were considered abnormal if below 50 m/s. Peak laten-
cies were considered abnormal if higher than 3.5 and 3.1 ms for
the median and ulnar nerves, respectively. Sensory nerve
conduction velocity and peak latency of the sural nerve were
considered abnormal if below 40 m/s and above 4.4 ms
respectively.
F-wave latencies were considered abnormal if higher than
31, 56 ms for the median and peroneal nerves, respectively.
F-wave frequencies less than 50 % were considered abnormal
in all the studied nerves.
Statistical analysis: Data were analyzed using SPSS soft-
ware package version 18.0 (SPSS, Chicago, IL, USA). Quanti-
tative data were expressed using range, mean and standard
deviation, while qualitative data were expressed in frequency
and percent. Quantitative data were analyzed using Mann–
Whitney test & Spearman coefﬁcient. The p value was assumed
to be signiﬁcant at 0.05 or less.(left) 3.7–5.3 4.51 ± 0.58
Median n. F wave frequency (right) 18–85% 57 ± 0.21
(left) 0–74% 53 ± 0.21
Peroneal n. F wave frequency (right) 0–70% 32 ± 0.28
(left) 0–72% 36 ± 0.293. Results
3.1. Demographic data
This study included 18 patients suffering from BD. They were
11 males and 7 females. Their ages ranged from 19 to 43 years
and their disease durations ranged from 2 to 17 years.
3.2. Clinical and electrophysiological characteristics
Patients involved in this study had disease activities ranging
from 0 to 13, their scores in the TNS ranged from 0 to 2. By
clinical examination, 2 patients (11.1%) had sensory symptoms
in the form of tingling and numbness, 4 patients (22.2%) had
reduced sensation up to the wrist and/or ankle and 2 patients
had motor manifestations in the form of mild distal weakness.
None of our patients had lost reﬂexes. The demographic and
clinical characteristics in BD patients are shown in Table 1.
Table 2 presents the nerve conduction study ﬁndings in BD
patients
3.3. Abnormal electrophysiological ﬁndings in BD patients
Table 3 demonstrates the frequencies of electrophysiological
abnormalities in BD patients. The most prominent electro-
physiological abnormality in BD patients was the abnormal
sural nerve latency and conduction velocity. Sensory nerveconduction studies of ulnar, median and sural nerves
(16.6%, 22.2%, 50% respectively) were more affected than
motor nerve conduction studies of the ulnar, median, tibial
and peroneal nerves (11.1%, 5.6%, 16.7%, 11.1% respectively)
and the difference was signiﬁcant (t= 4.3, p< 0.05).
3.4. Correlations between Behc¸et’s disease duration and disease
activity and the most frequent electrophysiological abnormalities
Sural nerve latencies were signiﬁcantly correlated with the dis-
ease duration (p< 0.05) (Fig. 1), and the peroneal F wave fre-
quencies showed statistically signiﬁcant negative correlations
with the disease duration (p< 0.05) (Fig. 2).
Regarding disease activity, there were positive correlations
between sural nerve latencies and disease activity scores and
negative correlations between the peroneal F wave frequencies
& disease activity scores, but these correlations did not reach
statistically signiﬁcant levels (p> 0.05).
4. Discussion
The central nervous system is frequently involved in BD, but
peripheral neuropathy, which is seen frequently in other
Table 3 Frequencies of electrophysiological abnormalities in
Behc¸et’s disease patients.
The studied nerve Abnormality
N (%)
Latency and conduction velocity
Ulnar nerve Motor (right) 1 (5.6)
(left) 1 (5.6)
Sensory (right) 3 (16.6)
(left) 4 (22.2)
Median nerve Motor (right) 1 (5.6)
(left) 0 (0)
Sensory (right) 4 (22.2)
(left) 4 (22.2)
Tibial nerve Motor (right) 2 (11.1)
(left) 1 (5.6)
Peroneal nerve Motor (right) 1 (5.6)
(left) 1 (5.6)
Sural nerve (right) 9 (50)
(left) 8 (44.4)
F wave frequency
Median nerve (right) 6 (33.3)
(left) 5 (27.8)
Peroneal nerve (right) 9 (50)
(left) 7 (41.2)
Figure 2 Correlation between right peroneal F wave frequencies
and disease duration in Behc¸et’s disease patients.
Figure 1 Correlation between right sural nerve latencies and
disease duration in Behc¸et’s disease patients.
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case reports and studies have revealed the involvement of the
peripheral nervous system. In 2005, Ghorbel et al. reported a
47 year old male with 6 year duration BD with paresthesia
and weakness of the upper and lower limbs, diarrhea and erec-
tile dysfunction & EMG evidence of axonal sensorimotor neu-
ropathy and nerve biopsy showing axonal neuropathy [22]. In
2007, Akubulat et al. performed an electrophysiological study
on Behc¸et patients and stated that they may have subclinical
peripheral nerve involvement [16]. Eun and colleagues
reported a 39-yr-old female patient presenting with recurrent
tibial neuropathy and concluded that BD should be considered
in patients with idiopathic recurrent mononeuropathy [23]. In
this study, we assessed the peripheral nervous system in BD
patients both clinically and electrophysiologically.
In our study, patients presenting with sensory manifesta-
tions (22.2%) were more than those presenting with motor
manifestations (11.1%). Sensory nerve conduction studies ofulnar, median and sural nerves (16.6%, 22.2%, 50% respec-
tively) were more affected than motor nerve conduction studies
of the ulnar, median, tibial and peroneal nerves (11.1%, 5.6%,
16.7%, 11.1% respectively) and the difference was signiﬁcant
(t= 4.3, p< 0.05). These ﬁndings were similar to those of
Akubulat et al., who also stated that sensory nerves were
affected more prominently than motor nerves [16]. Birol
et al., hypothesized that the nerve dysfunction or peripheral
neuropathy of BD is a distal polyneuropathy that predomi-
nantly involves the lower extremities [24]. This hypothesis goes
with our study in which the sural nerve was the most fre-
quently affected nerve in our patients (50%).
F waves were affected in (50%) of our patients in the form
of infrequent F waves, these ﬁndings were similar to those of
Budak et al., who also studied conventional nerve conduction
studies in Behc¸et patients and found that the F wave persis-
tence was decreased [25].
In our study right and left sural nerve latencies correlated
signiﬁcantly with the disease duration (r= 0.529, p< 0.05
and r= 0.598, p< 0.01). No signiﬁcant correlation was found
between right & left sural nerve latencies and disease activity
scores (r= 0.147, p> 0.05 and r= 0.286, p> 0.05 respec-
tively). Correlations between F wave frequencies and disease
duration were signiﬁcant for Rt & Lt peroneal (r= 0.56,
p< 0.01 and r= 0.518, p< 0.05 respectively). Correlations
between F wave frequencies and disease activity were non-sig-
niﬁcant (p> 0.05) for Rt and left peroneal and median nerves.
These ﬁndings were similar to those of Akubulat et al., who
found no signiﬁcant difference between the clinical parameters
of the patients with and without electrophysiologically
detected neuropathy, except disease duration [16].
From this work we conclude that peripheral nerve involve-
ment is present in BD. Peripheral nerve affection in BD is pre-
dominantly sensory affecting the lower limbs. The longer the
disease duration the more the peripheral nerves are affected.
Full neurological assessment and electrophysiological studies
including nerve conduction and F waves are necessary in the
follow up of Behc¸et patients.
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